The FDA approved Roche’s monoclonal antibody to treat COVID-19 Dec. 21, about three weeks after the agency reversed its authorization for Eli Lilly’s monoclonal drug.
Read the full post on Becker's Hospital Review - Healthcare News
Monoclonal drug wins approval after FDA revoked Eli Lilly's COVID-19 drug
